John P. Feighner
#160,293
Most Influential Person Now
John P. Feighner's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is John P. Feighner Influential?
(Suggest an Edit or Addition)John P. Feighner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnostic criteria for use in psychiatric research. (1972) (5375)
- Distinct mechanism for antidepressant activity by blockade of central substance P receptors. (1998) (1020)
- Bupropion: a review of its mechanism of antidepressant activity. (1995) (733)
- Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. (2002) (448)
- Mechanism of action of antidepressant medications. (1999) (281)
- Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial (1998) (272)
- Venlafaxine for treatment-resistant unipolar depression. (1994) (186)
- Comparison of alprazolam, imipramine, and placebo in the treatment of depression. (1983) (184)
- A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients (1991) (180)
- A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. (1982) (176)
- Clinical Effects of the 5‐HT1A Partial Agonists in Depression: A Composite Analysis of Buspirone in the Treatment of Depression (1990) (175)
- Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. (1985) (161)
- A family study of Gilles de la Tourette syndrome. (1976) (154)
- A 102-center prospective study of seizure in association with bupropion. (1991) (150)
- A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks (1998) (144)
- Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. (1994) (138)
- Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. (1985) (135)
- A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. (1998) (133)
- Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. (1999) (128)
- Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline (1991) (127)
- Fluoxetine-induced weight loss in overweight non-depressed humans. (1987) (122)
- Adverse consequences of fluoxetine-MAOI combination therapy. (1990) (120)
- Double-blind comparison of bupropion and fluoxetine in depressed outpatients. (1991) (115)
- Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. (1985) (108)
- Serotonin-1A anxiolytics: an overview. (1989) (100)
- Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. (1992) (96)
- Hormonal potentiation of imipramine and ECT in primary depression. (1972) (93)
- Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. (1994) (88)
- Cardiovascular safety in depressed patients: focus on venlafaxine. (1995) (84)
- Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Combination Therapy in the Treatment of Depression (1971) (83)
- A study comparing paroxetine placebo and imipramine in depressed patients. (1993) (80)
- Overview of antidepressants currently used to treat anxiety disorders. (1999) (79)
- Paroxetine in the treatment of depression: a comparison with imipramine and placebo (1989) (78)
- A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. (1989) (77)
- Venlafaxine: a new dimension in antidepressant pharmacotherapy. (1993) (76)
- A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. (1989) (70)
- A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients. (1990) (64)
- Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients. (1998) (62)
- A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. (1989) (56)
- Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder. (1986) (56)
- The role of venlafaxine in rational antidepressant therapy. (1994) (52)
- Double-blind multicenter comparison of fluvoxamine versus sertraline in the treatment of depressed outpatients (1995) (48)
- A Double‐Blind Comparison of Paroxetine With Imipramine in the Long‐Term Treatment of Depression (1993) (48)
- An overview of paroxetine. (1992) (47)
- Citalopram treatment of fluoxetine nonresponders. (2001) (46)
- Long-Term Safety and Clinical Acceptability of: Venlafaxine and Imipramine in Outpatients (1994) (44)
- An Overview of Fluoxetine in Geriatric Depression (1988) (44)
- Trazodone, a triazolopyridine derivative, in primary depressive disorder. (1980) (40)
- A double-blind study of bupropion and placebo in depression. (1984) (39)
- A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. (1998) (37)
- ELECTROSLEEP THERAPY: A Controlled Double Blind Study (1973) (36)
- Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone. (1989) (35)
- A placebo‐controlled double‐blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder (1993) (32)
- Selective serotonin re-uptake inhibitors : advances in basic research and clinical practice (1996) (31)
- Overview of USA controlled trials of trazodone in clinical depression (2004) (30)
- A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. (1985) (28)
- Safety of high-dose tricyclic antidepressant therapy. (1972) (26)
- A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. (1984) (26)
- A double‐blind comparison of alprazolam Vs. imipramine and placebo in the treatment of major depressive disorder (1983) (26)
- A double blind comparison of lofepramine, imipramine and placebo in patients with primary depression (1982) (25)
- Bupropion in tricyclic antidepressant nonresponders with unipolar major depressive disorder. (1994) (24)
- Clinical Efficacy of the Newer Antidepressants (1981) (23)
- The use of bupropion in hospitalized depressed patients. (1983) (22)
- A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression. (2000) (22)
- Antidepressants: Past, Present and Future (2004) (20)
- Benzodiazepines as Antidepressants (1982) (20)
- Paroxetine in the treatment of depression: a comparison with imipramine and placebo. (1992) (19)
- A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders. (1983) (19)
- Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression (2001) (19)
- Nosology of primary affective disorders and application to clinical research (1981) (18)
- Tricyclic antidepressants and monoamine oxidase inhibitors. (1971) (17)
- Cluster analysis of clinical data to identify subtypes within a study population following treatment with a new pentapeptide antidepressant. (2000) (16)
- An overview of fluoxetine, a new serotonin-specific antidepressant. (1989) (15)
- A Double‐Blind Comparison of Paroxetine, Imipramine and Placebo in Depressed Outpatients (1992) (14)
- A controlled trial of adinazolam versus desipramine in geriatric depression. (1990) (14)
- Comparisons of Maprotiline with Imipramine in Severe Depression: A Multicenter Controlled Trial (1979) (13)
- Buspirone in the long-term treatment of generalized anxiety disorder. (1988) (13)
- Antidepressants in the Treatment of Depression (1990) (11)
- A comparison of trazodone, amoxapine and maprotiline in the treatment of endogenous depression: results of a multicenter study (1984) (11)
- Impact of anxiety therapy on patients' quality of life. (1987) (11)
- Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder. (2006) (10)
- Long-term therapy for depression with trazodone. (1983) (10)
- Multimodality treatment of the hyperkinetic child. (1974) (9)
- Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment. (2003) (9)
- Maintenance Antidepressant Therapy: A Double-Blind Comparison of Trazodone and Imipramine (1981) (8)
- The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. (1999) (8)
- Comprehensive Textbook of Psychiatry, 3rd ed., vols. 1-3 (1981) (7)
- Clinical significance of early non‐response in depressed patients (1994) (7)
- Clinical overview of serotonin re-uptake inhibitors (1992) (7)
- Compliance and quality of response are major contributors to cost‐effective antidepressant therapy (1994) (7)
- Clinical pharmacokinetic studies with INN 00835 (Nemifitide), a novel pentapeptide antidepressant (2002) (7)
- Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients (2008) (7)
- A double‐blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders (1983) (7)
- Cost Analysis of Paroxetine versus Imipramine in Major Depression (1995) (7)
- The diagnosis of depression (1991) (6)
- Pilot study of alpidem, a novel imidazopyridine compound, in anxiety. (1988) (6)
- The effect of treatment with a new antidepressant: INN 00835 on platelet serotonin uptake in depressed patients (1998) (6)
- The new generation of antidepressants. (1983) (6)
- Discriminant analysis to separate a study population by treatment subgroups in a pilot clinical trial with a new pentapeptide antidepressant (INN 00835) (2001) (5)
- Open label study of alprazolam in severely depressed inpatients. (1983) (4)
- A review of controlled studies of adinazolam mesylate in patients with major depressive disorder. (1986) (4)
- Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression. (1982) (4)
- Pharmacology: New Antidepressants (1980) (4)
- P-2-87 Comparison of the safety and tolerance of fluvoxamine and sertraline in depressed outpatients (1995) (4)
- Utility of SSRIs in Anxious Depression (2001) (4)
- Nosology: a voice for a systematic data-oriented approach. (1979) (3)
- Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients. (1984) (3)
- [Diagnosis criteria from the Saint Louis school (Missouri-USA)]. (1978) (3)
- [Clinical effects of serotonin reuptake inhibitors--a review]. (1994) (3)
- A double blind comparison of lofepramine, imipramine and placebo in patients with depression. (1982) (3)
- Efficacy and safety of fezolamine in depressed patients. (1987) (3)
- Electrosleep therapy: current usage in psychiatry. (1971) (2)
- Mechanism of action of antidepressant medications. Discussion (1999) (2)
- 86-3 A double-blind trial of nefazodone versus placebo in depressed inpatients (1997) (2)
- Trazodone in major affective disorders. (1984) (2)
- Promising new directions in antidepressant development (2004) (2)
- [Review of studies of trazodone at the Feighner Research Institute in ambulatory and hospitalized patients]. (1986) (1)
- P.1.048 Metabolism phenotype and in vitro drug-drug interaction studies with nemifitide, a novel pentapeptide antidepressant (2003) (1)
- Preclinical and clinical overview of nemifitide, a novel antidepressant (2002) (1)
- Preclinical and clinical overview of INN 00835, a novel pentapeptide antidepressant (2001) (0)
- The Role of Trazodone in Antidepressant Therapy: Safety and Clinical Efficacy (1984) (0)
- P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder (2005) (0)
- Citalopram is effective and well tolerated in patients with major depressive disorder (1998) (0)
- Substance P (1998) (0)
- Using cluster analysis to identify subtypes within a study population following treatment with a new pentapeptide antidepressant (statistical and clinical aspects) (2000) (0)
- Plasma trimipramine levels. (1989) (0)
- Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder (2006) (0)
- P.1.011 Meta-analysis of efficacy of two pilot clinical studies with a novel pentapeptide antidepressant, nemifitide, in the treatment of depression (2003) (0)
- P-4-10 Efficacy of nefazodone versus placebo in a double-blind trial of depressed inpatients (1996) (0)
- VENLAFAXINE VS. IMIPRAMINE FOR THE TREATMENT OF DEPRESSION (1992) (0)
- Contents, Vol. 17, Supplement 2, 1984 (1984) (0)
- Effects of nemifitide on brain NPY levels and swim test immobility in a genetic animal model of depression (2002) (0)
- Combination Therapy in the Treatment of Depression (2016) (0)
- Contents, Vol. 22, Supplement 1, 1989 (1989) (0)
- Efficacy and tolerability of short-term venlafaxine XR therapy for GAD. Results of short-term, double-blind, placebo-controlled trials. (1999) (0)
- 36. Clinical profile of substance P antagonists (2000) (0)
- Psychiatry specialty board review : 1,400 multiple choice questions with referenced explanatory answers plus patient management clinical competence cases (1977) (0)
- CLINICAL EXPERIENCE WITH A NEW ANTIPSYCHOTIC WITHOUT DOPAMINE RECEPTOR BLOCKING PROPERTIES (1984) (0)
- Clinical evidence that substance P antagonists are well-tolerated antidepressants (2000) (0)
- The safety and efficacy of alprazolam, imipramine, and placebo in the treatment of depression (1983) (0)
- Psychiatry specialty board review : 1,122 multiple choice questions and referenced answers (1973) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John P. Feighner?
John P. Feighner is affiliated with the following schools:
